Private Equity 3 Days

Last updated: June 17, 2026, 5:30 PM ET

SpaceX Board Expansion

A former Sequoia Capital partner has stepped into a vacancy on the board of the space‑flight company that just completed the largest IPO in history, a move that could signal the firm’s intent to sharpen its governance as it scales. Roelof Botha’s appointment follows SpaceX’s $3.1bn market cap after the public debut, positioning the company to attract institutional oversight while it continues to diversify beyond rockets. The addition of a seasoned venture veteran may also pave the way for future capital raises or strategic partnerships as the company looks to monetize its satellite and launch services business. Botha joins board

Infrastructure and Health‑Tech Accretions

Private‑equity sponsors are tightening up their footprints in two high‑growth sectors. KPS Capital’s $225 m investment in the Australian infrastructure‑products provider Jennmar comes with a clause that lets existing shareholder Falcon Point Partners retain a sizeable minority stake, a structure that keeps the governance balance while injecting fresh capital for expansion. Meanwhile, a consortium led by Blackstone, Apollo and KKR is set to take control of the customer‑experience software group Medallia from Thoma Bravo, a deal that will likely unlock synergies across the two firms’ technology portfolios. Both transactions underscore a broader trend of PE firms deploying capital into infrastructure and software assets that can generate stable cash flows amid a competitive funding environment. Jennmar investment Medallia takeover

Health‑Tech Take‑Privates

The health‑tech sector continues to attract sizeable private‑equity interest. Altaris announced a $375 m take‑private of the simulation‑based medical training firm Simulations Plus, offering stockholders $18.50 per share. The deal values the company at roughly $12.9bn and reflects the growing appetite for digital health platforms that can improve clinical outcomes while reducing training costs. In a complementary move, Singlepoint Healthcare, backed by DFW Capital, acquired the infusion‑services provider Healix, adding a specialty care layer to its inflammatory‑disease focus and expanding its geographic reach in the United States. These two transactions illustrate how PE investors are layering complementary services within the broader health‑tech ecosystem to capture cross‑sell opportunities. Altaris acquisition

Secondaries Acceleration

The secondaries market is accelerating, driven by a mix of portfolio rebalancing and opportunistic exits. Flexstone’s purchase of the PE secondaries firm Glouston will create a platform that manages more than $15bn in assets, a move that bolsters Flexstone’s footprint in a market that has seen a surge in deal activity as funds look to liquidate positions ahead of upcoming lock‑up expirations. The acquisition comes at a time when institutional investors are increasingly comfortable with secondary transactions, as evidenced by GIC’s near $2bn sale of private‑credit assets to tap the booming secondaries market. These developments point to a maturing secondaries landscape where both buyers and sellers are leveraging scale to negotiate favorable terms. Glouston acquisition GIC sale

Digital‑Infrastructure Commitments

Canadian pension fund CPP Investments is deepening its exposure to India’s fast‑growing digital‑infrastructure market by committing up to $715 m to a partnership with Ctrl S Datacenters. The investment will help scale the provider’s data‑centre platform across the country, a move that aligns with CPP’s strategy to diversify into high‑growth, infrastructure‑heavy sectors. Similarly, Clearlake Capital’s recent closure of its eighth flagship fund at $14.8bn, with a focus on AI, signals a broader shift toward technology‑enabled infrastructure as a core asset class for large, established PE managers. These capital deployments illustrate how traditional pension and endowment funds are reallocating capital toward resilient, high‑growth infrastructure and technology sectors in a low‑yield environment. CPP investment Clearlake fund

AI‑Enabled Software and Data Platforms

The private‑equity appetite for AI‑enabled software remains robust. A recent $2.75bn take‑private of Payoneer by Advent‑backed Nuvei is a testament to the sector’s liquidity and the strategic value of payment‑processing platforms in an increasingly digital economy. Concurrently, the acquisition of the enterprise AI platform Scope AR by Flatirons, backed by Teleo, underscores the trend of PE firms targeting niche AI solutions that can be integrated across aerospace, defense, and industrial sectors. These deals demonstrate how PE investors are positioning themselves to benefit from the accelerating adoption of AI across traditional industries. Nuvei acquisition

Capital Raising Challenges

Fund managers face a tougher fundraising environment, with limited liquidity and heightened due diligence. The PE landscape is witnessing an increase in continuation funds, such as the $780 m vehicle closed by Abry Partners for Centauri Health Solutions, a move that reflects the growing need to lock in capital for longer‑term, high‑margin healthcare assets. At the same time, the closed eighth flagship fund by Clearlake Capital signals a consolidation trend where larger managers are able to raise substantial sums while smaller funds struggle to find comparable traction. These dynamics suggest that capital deployment decisions will become increasingly strategic, focusing on high‑barrier‑to‑entry sectors and value‑creation opportunities that can withstand tighter investor scrutiny. Abry continuation Clearlake fund

Conclusion

The past three days have highlighted a continued focus among private‑equity players on infrastructure, health‑tech, and AI‑enabled software, while secondaries and capital‑raising strategies evolve to meet the demands of a competitive, low‑interest-rate environment. Board appointments at high‑profile companies, sizable take‑privates, and significant capital commitments to digital infrastructure all point to a sector that remains dynamic and opportunistic, even as it navigates regulatory and market headwinds.